AR and adenocarcinoma: Clinical characteristics of NE/SC are quite different from that of CRPC adenocarcinoma, and they are often exemplified by low serum PSA, high serum NE markers (e.g., chromogranin A, neuron-specific enolase), visceral metastasis, and poor response to AR-targeted therapies [26].